The interplay between ET-1 signaling and mTOR under hyperglycemic conditions in cardiomyocytes needs to be further investigated to unveil potential drug targets to treat diabetic cardiomyopathies. The gene discussed is EDN1; the disease is diabetic cardiomyopathy.